Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. [electronic resource]
- Free radical research Nov 2010
- 1369-77 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1029-2470
10.3109/10715762.2010.509399 doi
Angiotensin II Type 1 Receptor Blockers--pharmacology Animals Antibiotics, Antineoplastic--adverse effects Blotting, Western Daunorubicin--adverse effects Heart--drug effects Imidazoles--pharmacology Immunohistochemistry Male Myocardium--pathology Oxidative Stress--drug effects Rats Rats, Sprague-Dawley Tetrazoles--pharmacology